Document is current
Any future updates will be listed below
-
Authors
Umulisa, M. Chantal
Franceschi, Silvia
Baussano, Iacopo
Tenet, Vanessa
Uwimbabazi, Mathilde
Rugwizangoga, Belson
Heideman, Daniëlle A. M.
Uyterlinde, Anne M.
Darragh, Teresa M.
Snijders, Peter J. F.
Sayinzoga, Felix
Clifford, Gary M. https://orcid.org/0000-0001-7534-333X
-
Funding
Funding for this research was provided by:
Centre International de Recherche sur le Cancer
Bill and Melinda Gates Foundation (35537 / OPP1053353)
- License Information
-
More Information
Article History
Received: 26 September 2017
Accepted: 9 April 2018
First Online: 24 April 2018
Ethics approval and consent to participate
: The study had the approval of both the Research Ethical Board of the Rwanda Ministry of Health and the IARC Ethics Committee. Written informed consent was obtained from all study participants.
: PJFS has Honoraria from Speakers Bureau from Roche diagnostics, Gen-Probe, Abbott, Seegene, and Qiagen, and has been a consultant/advisory board member for Crucell BV. DAMH serves occasionally on the scientific advisory board of Pfizer. PJFS and DAMH are minority shareholders of Self-screen B.V., a spin-off company of VUmc which holds patents related to the work. TMD has Honoraria from Roche. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
